Crescent Jumps Into VEGFxPD-1 Bispecific Race Via Merger With GlycoMimetics

 
• By Joseph Haas
  
Crescent will go public via a merger with troubled GlycoMimetics. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Therapy Areas